Target Name: MIR4768
NCBI ID: G100616249
Other Name(s): microRNA 4768 | MicroRNA 4768 | hsa-mir-4768 | hsa-miR-4768-5p | hsa-miR-4768-3p

MIR4768: A Potential Drug Target and Biomarker for Obesity

Obesity is a significant public health issue, with an estimated global prevalence of 285 million adults worldwide. The increasing obesity crisis has led to a range of chronic diseases, including diabetes, cardiovascular disease, and certain cancers. In addition, obesity has also been associated with various other health problems, such as sleep apnea, osteoarthritis, and certain neurological disorders. As such, identifying potential drug targets and biomarkers for obesity is of great importance. In this article, we will focus on one such potential drug target and biomarker, MIR4768.

MIR4768 is a gene that has been identified as a potential drug target and biomarker for obesity. The MIR4768 gene is located on chromosome 12q34 and encodes for a non-coding RNA molecule known as MIR4768. MIR4768 has been shown to play a role in the regulation of body weight and appetite in both humans and animals.

Studies have shown that MIR4768 is highly expressed in human obese tissues, including fat tissue, and is downregulated in human lean tissue. This downregulation of MIR4768 has been associated with increased levels of a protein called Transthyretin (TRETN), which has been shown to play a role in the regulation of body weight and appetite.

In addition, MIR4768 has also been shown to be involved in the regulation of bone density, as has been observed in individuals with obesity. This is important as bone density is a critical factor in overall bone health and is associated with various diseases, including osteoporosis and certain cancers.

Furthermore, MIR4768 has also been shown to be involved in the regulation of insulin sensitivity, which is important in the development of type 2 diabetes. Insulin sensitivity is associated with various factors, including body weight, and is often reduced in individuals with obesity.

In conclusion, MIR4768 is a gene that has been identified as a potential drug target and biomarker for obesity. The evidence suggests that MIR4768 is involved in the regulation of body weight, appetite, bone density, and insulin sensitivity, all of which are important in the development and progression of obesity. Further research is needed to fully understand the role of MIR4768 in obesity and to explore its potential as a drug target.

Protein Name: MicroRNA 4768

More Common Targets

MIR4769 | MIR4770 | MIR4771-1 | MIR4771-2 | MIR4772 | MIR4773-1 | MIR4773-2 | MIR4774 | MIR4775 | MIR4776-1 | MIR4776-2 | MIR4777 | MIR4778 | MIR4779 | MIR4780 | MIR4781 | MIR4782 | MIR4783 | MIR4784 | MIR4785 | MIR4786 | MIR4787 | MIR4789 | MIR4790 | MIR4791 | MIR4793 | MIR4794 | MIR4795 | MIR4796 | MIR4797 | MIR4798 | MIR4799 | MIR4800 | MIR4802 | MIR4803 | MIR4804 | MIR483 | MIR484 | MIR485 | MIR486-1 | MIR486-2 | MIR487A | MIR487B | MIR488 | MIR489 | MIR490 | MIR491 | MIR492 | MIR493 | MIR494 | MIR495 | MIR496 | MIR497 | MIR497HG | MIR498 | MIR4999 | MIR499A | MIR499B | MIR5000 | MIR5001 | MIR5002 | MIR5003 | MIR5004 | MIR5006 | MIR5007 | MIR5008 | MIR5009 | MIR500A | MIR500B | MIR501 | MIR5010 | MIR5011 | MIR502 | MIR503 | MIR503HG | MIR504 | MIR5047 | MIR505 | MIR506 | MIR507 | MIR508 | MIR5088 | MIR5089 | MIR509-1 | MIR509-2 | MIR509-3 | MIR5090 | MIR5091 | MIR5092 | MIR5093 | MIR5094 | MIR510 | MIR5100 | MIR511 | MIR511-2 | MIR512-1 | MIR512-2 | MIR513A1 | MIR513A2 | MIR513B